A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma.Ritesh Kotecha,Chung-Han Lee,Deaglan Joseph McHugh,Chloe Dadoun,Andrea Knezevic,Maria Isabel Carlo,Emily Feld,Natalie Shapnik,Neil J. Shah,Darren R. Feldman,Robert J. Motzer,Martin H. VossJOURNAL OF CLINICAL ONCOLOGY(2022)引用 1|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要